Correction to “Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell‐Penetrative MMP‐2‐Cleavable Peptide”
Dan Hua, Lida Tang, Weiting Wang, Shengan Tang, Lin Yu, Xuexia Zhou, Qian Wang, Cuiyun Sun, Cuijuan Shi, Wenjun Luo, Zhendong Jiang, Huining Li, Shizhu Yu
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGlioma Diagnosis and Treatment · Nanoparticle-Based Drug Delivery · Ubiquitin and proteasome pathways
Adv. Sci. 2021, Feb. 8(3):2001960
https://doi.org/10.1002/advs.202001960
In the Supporting Information of the original publication, the independent image representing the migration in the U251 without the MMP‐2 siRNA group was incorrectly presented in Figure S2 (Supporting Information). The correct image should be as follows:
We apologize for this error.